Our Healthcare News

TELA Bio Awarded Contract with HealthTrust Purchasing Group

MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement…  

Dec 06 2019

Knight Therapeutics Announces Closing of Previously Announced Acquisition of Grupo Biotoscana

MONTREAL, Canada—Knight Therapeutics Inc. (TSX: GUD) (“Knight”) today announced that it has completed the acquisition of a 51.2% interest in Biotoscana Investments S.A. (B3: GBIO33)…  

Nov 29 2019

Sonendo Named to Inc. 5000 List of Fastest-Growing Private Companies

LAGUNA HILLS, California—Inc. magazine today revealed that Sonendo®, developer of the GentleWave® System, is No. 19 on its annual Inc. 5000 list of the nation’s…  

Oct 05 2019

Cognate BioServices Secures Growth Capital Investment from EW Healthcare to Continue to Expand Commercial Manufacturing Capacity and Services for the Cellular Therapies Industry

BALTIMORE & MEMPHIS, Tennessee –(BUSINESS WIRE)–Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has…  

Aug 26 2019

EW Healthcare Partners Raises Over $745 Million Fund 2

Team of Experienced Healthcare Investors and Former Healthcare Executives Will Invest in Select Healthcare Companies to Seek to Accelerate Their Revenue Growth

Partner and Principals…  

Aug 22 2019

LightStrike Robot Proven Effective at Destroying Deadly Superbug Candida auris in New Published Study

SAN ANTONIO—(BUSINESS WIRE)—Candida auris (C.auris) is an emerging, often multi-drug resistant, fungus that causes serious and often deadly infections in healthcare settings. The Centers for…  

Jul 08 2019

EyePoint Pharmaceuticals Added to Russell 3000® and 2000® Indexes

WATERTOWN, Massachusetts—(GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) (“Eyepoint”), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that the Company…  

Jul 01 2019

TissueTech Raises $82 Million in Latest Round of Equity Financing

EW Healthcare Partners Managing Director Martin Sutter and Former Medtronic CEO Bill Hawkins join TissueTech Board of Directors

(PRWEB) MIAMI, Florida—TissueTech, Inc., the pioneer in…  

Jun 26 2019

Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®.

MALVERN, Pennsylvania—Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute…  

Apr 02 2019

View Legacy Fund news >